Amlodipine5mgAtenololAmlodipine10mgAtenololAmlodipine10mgAtenololPerindopril4mgBFZAmlodipine10mgAtenololPerindopril8mgBFZAmlodipine10mgAtenololPerindopril8mgBFZDoxazosin4mgDoxazosinAmlodipine10mgAtenolol 50mg100mg100mg1.25mg100mg2.5mg100mg2.5mg4mg100mg RESULTScontd.Bloodpressurewaswellcontrolledinbotharmsofthestudy,but...
ASCOTpresentation.ppt,ASCOT- BPLA: Rationale Insufficient outcome data on newer types of BP-lowering agents, especially in specific combination treatment regimens Less-than-expected CHD prevention using standard therapy ASCOT- BPLA Additional objectives
2、of CHD and other vascular events by BP and cholesterol lowering in a factorial study design 对降压和降脂预防冠心病和其它血管事件的随机、对照、析因研究,ASCOT- BPLA: Rationale,Insufficient outcome data on newer types of BP-lowering agents, especially in specific combination treatment regimens Less...